NRAS (breast carcinoma and skin melanoma), CDK4 (NSCLC), and ERBB2 (gastric carcinoma and esophageal carcinoma) were identified as the top identified amplification driver genes in different cancer types (Supplementary Table 1). This evidence concerns the gene ERBB2 and breast carcinoma.